0

Cardiology Collection
 261-280 of 4958 Articles
Articles |  15 September 2009
The Net Value of Health Care for Patients With Type 2 Diabetes, 1997 to 2005
Karen N. Eggleston, PhD; Nilay D. Shah, PhD; Steven A. Smith, MD; et al.
Ann Intern Med. 2009;151(6):386-393. doi:10.7326/0003-4819-151-6-200909150-00003
Editorials |  1 September 2009
Do Current Guidelines Result in Overuse of Warfarin Anticoagulation in Patients With Atrial Fibrillation?
Robert G. Hart, MD; Jonathan L. Halperin, MD
Ann Intern Med. 2009;151(5):355-356. doi:10.7326/0003-4819-151-5-200909010-00012
Articles |  1 September 2009
Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Trial
Katherine Esposito, MD, PhD; Maria Ida Maiorino, MD; Miryam Ciotola, MD; et al.
Ann Intern Med. 2009;151(5):306-314. doi:10.7326/0003-4819-151-5-200909010-00004
Articles |  1 September 2009
The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
Daniel E. Singer, MD; Yuchiao Chang, PhD; Margaret C. Fang, MD, MPH; et al.
Ann Intern Med. 2009;151(5):297-305. doi:10.7326/0003-4819-151-5-200909010-00003
Academia and the Profession |  18 August 2009 FREE
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati, MD, DrPH; Douglas G. Altman, DSc; Jennifer Tetzlaff, BSc; et al.
Ann Intern Med. 2009;151(4):W-65-W-94. doi:10.7326/0003-4819-151-4-200908180-00136
Reviews |  4 August 2009 FREE
Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
Teruhiko Terasawa, MD; Ethan M. Balk, MD, MPH; Mei Chung, MPH; et al.
Ann Intern Med. 2009;151(3):191-202. doi:10.7326/0003-4819-151-3-200908040-00131
Editorials |  21 July 2009
Safer Fats for Healthier Hearts: The Case for Eliminating Dietary Artificial Trans Fat Intake
Julie Louise Gerberding, MD, MPH
Ann Intern Med. 2009;151(2):137-138. doi:10.7326/0003-4819-151-2-200907210-00012
Ideas and Opinions |  21 July 2009
Cholesterol Control Beyond the Clinic: New York City's Trans Fat Restriction
Sonia Y. Angell, MD, MPH; Lynn Dee Silver, MD, MPH; Gail P. Goldstein, MPH; et al.
Ann Intern Med. 2009;151(2):129-134. doi:10.7326/0003-4819-151-2-200907210-00010
Articles |  7 July 2009 FREE
Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes: Three Randomized Trials
Rudy Bilous, MD; Nish Chaturvedi, MD; Anne Katrin Sjølie, MD; et al.
Ann Intern Med. 2009;151(1):11-20. doi:10.7326/0003-4819-151-1-200907070-00120
Articles |  7 July 2009 FREE
Effect of Telmisartan on Renal Outcomes: A Randomized Trial
Johannes F.E. Mann, MD; Roland E. Schmieder, MD; Leanne Dyal, MSc; et al.
Ann Intern Med. 2009;151(1):1-10. doi:10.7326/0003-4819-151-1-200907070-00122
Editorials |  16 June 2009
Balancing Randomized Trials With Anecdote
Paul S. Phillips, MD
Ann Intern Med. 2009;150(12):885-886. doi:10.7326/0003-4819-150-12-200906160-00014
Reviews |  16 June 2009
Narrative Review: Statin-Related Myopathy
Tisha R. Joy, MD; Robert A. Hegele, MD
Ann Intern Med. 2009;150(12):858-868. doi:10.7326/0003-4819-150-12-200906160-00009
Articles |  16 June 2009
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial
David J. Becker, MD; Ram Y. Gordon, MD; Steven C. Halbert, MD; et al.
Ann Intern Med. 2009;150(12):830-839. doi:10.7326/0003-4819-150-12-200906160-00006
Editorials |  2 June 2009
Predicting Risk for Diabetes: Choosing (or Building) the Right Model
William H. Herman, MD, MPH
Ann Intern Med. 2009;150(11):812-814. doi:10.7326/0003-4819-150-11-200906020-00010
Ideas and Opinions |  2 June 2009
Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?
Victor M. Montori, MD, MSc; Mercè Fernández-Balsells, MD
Ann Intern Med. 2009;150(11):803-808. doi:10.7326/0003-4819-150-11-200906020-00008
Academia and the Profession |  2 June 2009
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures
Nancy R. Cook, ScD; Paul M Ridker, MD
Ann Intern Med. 2009;150(11):795-802. doi:10.7326/0003-4819-150-11-200906020-00007
Reviews |  2 June 2009
Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
Finlay A. McAlister, MD, MSc; Natasha Wiebe, MMath, PStat; Justin A. Ezekowitz, MD, MSc; et al.
Ann Intern Med. 2009;150(11):784-794. doi:10.7326/0003-4819-150-11-200906020-00006
Reviews |  2 June 2009
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
James R. Sowers, MD; Adam Whaley-Connell, DO; Murray Epstein, MD
Ann Intern Med. 2009;150(11):776-783. doi:10.7326/0003-4819-150-11-200906020-00005
Articles |  2 June 2009
Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years
Henry S. Kahn, MD; Yiling J. Cheng, MD, PhD; Theodore J. Thompson, MS; et al.
Ann Intern Med. 2009;150(11):741-751. doi:10.7326/0003-4819-150-11-200906020-00002
Academia and the Profession |  19 May 2009
Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin II–Receptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?
Ann M. O'Hare, MD; James S. Kaufman, MD; Kenneth E. Covinsky, MD, MPH; et al.
Ann Intern Med. 2009;150(10):717-724. doi:10.7326/0003-4819-150-10-200905190-00010
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)